Back to BIIB

BIOGEN INC. Capital Expenditures 2007-2026 | BIIB

Beta

What is capital expenditures?

Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.

What is BIOGEN INC.'s current capital expenditures?

BIOGEN INC. (BIIB) annual capital expenditures for 2025 was $153.8M, a 0.07% increase from 2024. BIOGEN INC. capital expenditures for the quarter ending March 31, 2026 was $51.2M.

What was BIOGEN INC.'s capital expenditures in 2024?

BIOGEN INC. annual capital expenditures for 2024 was $153.7M, a 44.51% decline from 2023.

What was BIOGEN INC.'s capital expenditures in 2023?

BIOGEN INC. annual capital expenditures for 2023 was $277.0M, a 15.27% increase from 2022.

What is BIOGEN INC.'s 5-year capital expenditures CAGR?

BIOGEN INC. capital expenditures grew at a compound annual growth rate (CAGR) of 18.39% from FY2020 to FY2025, going from $424.8M to $153.8M over 5 years.

Capital Expenditures History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR-18.4%
FY2020
$424.8M
→
FY2025
$153.8M
07080910111213141516171819202122232425
5 years selected
Capital Expenditures History
PeriodValueChangeSource
FY2025$153.8M+0.1%10-K
FY2024$153.7M-44.5%10-K
FY2023$277.0M+15.3%10-K
FY2022$240.3M-6.9%10-K
FY2021$258.1M-39.2%10-K
FY2020$424.8M-17.4%10-K
FY2019$514.5M-33.2%10-K
FY2018$770.6M-11.2%10-K
FY2017$867.4M+40.8%10-K
FY2016$616.1M-4.2%10-K
FY2015$643.0M+123.4%10-K
FY2014$287.8M+16.8%10-K
FY2013$246.3M-3.2%10-K
FY2012$254.5M+22.4%10-K
FY2011$208.0M+20.2%10-K
FY2010$173.1M+4.5%10-K
FY2009$165.6M-40.0%10-K
FY2008$276.0M-2.9%10-K
FY2007$284.1M-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →